$3M Apyx Settlement In Securities Suit Gets Initial OK
Law360 (July 22, 2020, 8:47 PM EDT) -- A Florida federal judge has greenlit a $3 million cash settlement resolving class action claims that plastic surgery device manufacturer Apyx Medical Corp. concealed disappointing study results for a skin-tightening product from its shareholders.
U.S. District Judge Susan C. Bucklew granted preliminary approval Tuesday of the deal proposed on July 10, which said the $3 million represents a recovery of about 16.4% of the total potential maximum damages available in the suit.
Judge Bucklew also certified a class of investors who bought Apyx stock or options or sold out options between Dec. 21, 2018, and April 1, 2019, for settlement purposes only....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!